Director Contract Manufacturing

Oriol Prat

Advancing Patient-Centric Parenteral Drug Strategies
Thursday, September 29, 2016
For the foreseeable future, therapies delivered via parenteral routes will dominate advancements in healthcare and patient outcomes. Regulators, governments, health systems and — most importantly — patients are all ... read more
A Holistic Interpretation of Commitment to Quality
Saturday, April 30, 2016
Demand for injectable drug products is increasing at a healthy rate, due in part to growth of the biologics market and because injectable formulations offer a mechanism for increasing the efficacy, while reducing the ... read more